U.S. Healthtech Stock News

Ever wondered if Colgate-Palmolive is truly a bargain or if the brand power is already priced in? Let’s dig in and see if there’s hidden value waiting to be uncovered. The stock has seen a modest bounce recently, up 2.2% in the last week and 1.0% over the past month, but it’s still down 13.0% year-to-date and off 12.9% over the last year. While overall market conditions have weighed on consumer staples, Colgate-Palmolive has been in the headlines for new product rollouts and increased...

DNOW just released its third-quarter earnings, highlighting stronger sales and a major jump in net income compared to last year. This report gives investors more insight into how the business has been trending in 2025. See our latest analysis for DNOW. Following DNOW’s upbeat third-quarter earnings report, the company’s share price has shown some volatility. It is up 5.6% year-to-date, but has experienced a 12.6% dip over the past month. While the recent announcement highlights stronger...

Pfizer (PFE) shares have been under quiet selling pressure this month, slipping just under 5% in that stretch. Investors are watching closely as the market continues to digest its recent results and the evolving pharmaceutical landscape. See our latest analysis for Pfizer. Pfizer’s share price has faded this year, with a year-to-date slip of 8.2 percent and the 1-year total shareholder return in the red at just under 2 percent. This underscores waning momentum even after a series of product...

Tower Semiconductor recently reported a 6.3% revenue increase to US$393.98 million for the September 2025 quarter, alongside earnings of 54 cents per share. Analysts continue to show unanimous positive sentiment toward the company, as reflected by the current absence of hold or sell recommendations. We'll explore how these expectations for quarterly growth and strong analyst confidence could reshape Tower Semiconductor's long-term investment narrative. These 13 companies survived and thrived...

Stagwell (STGW) shares have seen uneven movement over the month, with the stock recently closing at $4.82. For investors tracking its progress, Stagwell’s annual numbers show revenue growth along with a strong rise in net income. See our latest analysis for Stagwell. Stagwell’s share price has faced persistent downward pressure, with a 1-year total shareholder return of -38.6% and a year-to-date share price return of -25.5%. While recent bumps and volatility hint at shifting investor...

Neptune Insurance Holdings (NP) has caught investor attention this week, with shares closing at $26.86 and posting a 6% gain for the day. The stock’s recent move stands out against a backdrop of mixed performance within the insurance sector. See our latest analysis for Neptune Insurance Holdings. With a 1-day share price return of 6.2% and a year-to-date gain of 8.3%, Neptune Insurance Holdings is showing signs of renewed momentum following a modest dip over the past month. The latest uptick...

IBM was recently selected for Stage B of the U.S. Defense Advanced Research Projects Agency’s Quantum Benchmarking Initiative, highlighting external recognition of its quantum computing advancements and ongoing collaboration with SEEQC to explore novel scaling approaches. This announcement reinforces IBM’s position as one of only two companies with operational quantum computing technology, amplifying confidence in its competitive edge within this emerging field. We'll examine how IBM's...

Aon plc recently reported third quarter 2025 earnings, highlighting US$3.99 billion in revenue and US$458 million in net income, alongside executive changes in its Reinsurance Solutions division and the completion of a substantial share repurchase program. An interesting insight is that Aon's growth was bolstered by demand in commercial risk and reinsurance solutions, with the company reaffirming its full-year outlook and continued investment in client-focused talent and operational...

Pacira BioSciences (PCRX) shares have caught some attention recently, rising 4% in the past day. Investors are looking at how the stock’s momentum compares with longer-term trends and underlying business gains. See our latest analysis for Pacira BioSciences. While Pacira BioSciences’ 4.5% jump in share price over the last day certainly stands out, the bigger story is the stock’s 20.3% share price return year-to-date and a 27.9% total shareholder return over one year, despite several months of...

In recent days, PostFinance announced it will expand its use of FICO's Falcon Fraud Manager and Customer Communication Services to bolster fraud protection and customer engagement across 2.4 million Swiss customers and millions of transactions each day. This deepening collaboration highlights FICO's ability to secure growing transaction volumes with AI-powered solutions, reflecting continued demand for advanced fraud detection and real-time customer communication technologies in the global...

AutoNation (AN) just expanded its equity buyback plan by $1,000 million, bringing the total repurchase authorization to $11,500 million. This signals ongoing confidence from management in the company’s long-term outlook. See our latest analysis for AutoNation. AutoNation’s expanded buyback comes after a solid run, with a year-to-date share price return of 16.1% and a robust 1-year total shareholder return of 17.9%. While the past month saw softer momentum, the stock’s longer-term total...

Tootsie Roll Industries (NYSE:TR) released its third-quarter and nine-month results on November 7, showing increases in sales, revenue, and net income compared to last year. Investors are paying close attention to these steady gains. See our latest analysis for Tootsie Roll Industries. This latest report seems to have sparked a fresh wave of momentum for Tootsie Roll Industries, with the stock's share price up 2.14% in a day and a strong 18.98% gain so far this year. While the recent 30-day...

In early November 2025, Commercial Metals Company entered into a second amendment of its credit agreement to allow bridge facility loans and adjust certain default provisions, while also announcing director Sarah E. Raiss’s retirement and the resignation of Senior Vice President Jennifer J. Durbin by year-end. An interesting aspect is the company's ability to secure greater financing flexibility through the amended credit facility, supporting its ongoing expansion and operational...

Viking Therapeutics attracted fresh attention after presenting new VK2735 clinical trial data at ObesityWeek 2025. The company’s Phase 2 results revealed sustained weight loss, improved metabolic profiles, and a promising safety record for patients. See our latest analysis for Viking Therapeutics. Viking Therapeutics’ share price has seen some dramatic swings, with October’s 44.9% rally fueled by excitement over VK2735’s clinical progress and renewed acquisition speculation. Despite this...

McCormick (MKC) has unveiled a complete redesign of its Gourmet Collection packaging, marking the first major update in more than three decades. This move reflects the company's focus on quality, transparency, and responsible sourcing as it aims to engage Millennial and Gen Z consumers who are seeking new flavor experiences. See our latest analysis for McCormick. Shares of McCormick have faced headwinds lately, with a 1-year total shareholder return of -13.97%. This reflects broader concerns...

Merus (MRUS) has caught the attention of many investors after its stock saw significant gains over the past month, as well as even more dramatic growth during the past quarter. This rally raises new questions about its current valuation. See our latest analysis for Merus. Merus’s recent 90-day share price return of 48.8% is part of a much larger trend, with the stock posting a year-to-date gain of 125.1%. While the stock has seen a series of noteworthy gains over the past quarter, its...

Earlier this week, Aveanna Healthcare Holdings announced third quarter 2025 results with revenue of US$621.94 million and net income of US$14.06 million, a turnaround from a net loss in the same period last year. Management also raised its full-year revenue outlook and highlighted successful payer negotiations, integrated acquisitions, and improved caregiver workforce stability as major factors supporting ongoing momentum. We’ll explore how Aveanna’s raised full-year revenue guidance signals...

Palantir Technologies reported another record quarter, surpassing analyst estimates with revenue of US$1.18 billion in the third quarter of 2025 and raising its full-year revenue guidance, also announcing the creation of a joint venture in Dubai called Aither to expand AI adoption across key regional sectors. The company’s rapid expansion is highlighted by new partnerships with Nvidia and Dubai Holding, underlining Palantir’s role as a leading provider of applied AI solutions to both...

CubeSmart (CUBE) just released its third quarter earnings, showing year-over-year revenue growth. However, there was a dip in net income and earnings per share. The company also revised its full-year outlook upwards, which has caught investors’ attention. See our latest analysis for CubeSmart. Certainly, CubeSmart’s raised full-year guidance comes as its share price shows signs of pressure. Despite the positive revenue trend and continued dividends, the market response has been muted...

Federated Hermes' board declared a US$0.34 per share dividend, payable November 14, 2025, to shareholders of record as of November 7, following the release of third-quarter earnings showing increases in both revenue and net income compared to the prior year. These results highlight continued financial strength, with basic earnings per share from continuing operations rising to US$1.34 from US$1.06 year-over-year, and cumulative nine-month net income nearing US$300 million. We'll explore how...

In the past week, CoStar Group reported third quarter 2025 results showing revenue of US$833.6 million and a net loss of US$30.9 million, alongside issuing updated revenue guidance for the fourth quarter and full year 2025, and also announced completion of a US$114.78 million share buyback. While CoStar's most recent financial performance reflected a swing to net loss, the company provided guidance signaling substantial revenue growth continuing into the next quarter and year. We'll look at...

Kimbell Royalty Partners recently reported its third quarter 2025 results, with revenue of US$80.62 million and net income of US$19.68 million, both reflecting a year-on-year decrease, but with production exceeding guidance at 25,530 Boe per day and a declared distribution of US$0.35 per common unit. Despite sector-wide headwinds, Kimbell's operational resilience was evident through organic production growth and a continued focus on returning value to unit holders. We'll explore how...

Earlier this month, Carrier Global Corporation reported third quarter 2025 results, citing a year-over-year revenue decline to US$5.58 billion and a reduction in net income amid ongoing softness in North American residential sales and the European heating market. Alongside earnings, Carrier lowered its full-year 2025 sales guidance by US$1 billion, increased its share buyback authorization by US$5 billion, and highlighted new U.S. Department of Energy recognition for its heat pump training...

Ball (NYSE:BALL) has caught the market’s attention after reporting third quarter results that show clear year-over-year gains in both revenue and earnings. Investors are also watching new sustainability initiatives, including recent progress on low-carbon aluminum packaging. See our latest analysis for Ball. While Ball’s innovative moves and strong Q3 results have received positive attention, the share price has only inched up 1.24% over the last day and 4.21% in the past week. It remains...